Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 1—January 2007

Research

Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization

Rebecca H. Sunenshine*, Marc-Oliver Wright†, Lisa L. Maragakis‡, Anthony D. Harris†, Xiaoyan Song‡, Joan Hebden†, Sara E. Cosgrove‡, Ashley Anderson*, Jennifer Carnell*, Daniel B. Jernigan*, David G. Kleinbaum*, Trish M. Perl‡, Harold C. Standiford†, and Arjun Srinivasan*Comments to Author 
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †University of Maryland Medical School and Medical Center, Baltimore, Maryland, USA; ‡Johns Hopkins University, Baltimore, Maryland, USA;

Main Article

Table 4

Multivariable analysis of discordant versus concordant empiric antimicrobial drug therapy in patients with multidrug-resistant Acinetobacter infections, Baltimore hospitals, 2003–2004*

Outcome evaluatedDiscordant vs. concordant empiric antimicrobial drug therapy†
OR (95% CI)p value
Length of stay, d1.6 (0.4–6.5)0.54
Intensive care unit length of stay, d5.8 (1.2–27.1)0.03
Mortality rate (%)0.7 (0.1–4.5)0.74

*OR, odds ratio; CI, confidence interval.
†Model includes modified Acute Physiology and Chronic Health Evaluation III score to control for severity of illness and Charlson index to control for underlying disease.

Main Article

TOP